Stocks Comparison
McKesson vs DataMeds AI: revenue, profit, margins and growth compared
McKesson brought in $403.4B of revenue in fiscal 2026, DataMeds AI $23.3M in fiscal 2025. Revenue changed by +12.4% at McKesson and +28.7% at DataMeds AI on the year before, so DataMeds AI grew faster. McKesson kept 1.2% of its revenue as net profit, DataMeds AI -433.9%.
Side by side, latest fiscal year
| MCK | MEDS | |
|---|---|---|
| Fiscal year ended | FY2026 (March 31, 2026) | FY2025 (December 31, 2025) |
| Revenue | $403.4B | $23.3M |
| Revenue growth | +12.4% | +28.7% |
| Net income | $4.8B | -$101.3M |
| Net margin | 1.2% | -433.9% |
| Free cash flow | $5.7B | n/a |
| Free cash flow margin | 1.4% | n/a |
| Earnings per share (diluted) | $38.38 | -$1.43 |
| Cash | $4B | $42.6K |
| Debt | $6.5B | $23.5M |
| Price to earnings | 22.6 | n/a |
| Market value | $101B | $9.1M |
| Dividend yield | 0.37% | n/a |
| Rank by revenue in sector | #2 of 646 · Health care | #426 of 646 · Health care |
Over the years
Questions about McKesson and DataMeds AI
Which is bigger by revenue, McKesson or DataMeds AI?
McKesson is bigger by revenue: $403.4B in fiscal 2026, against $23.3M for DataMeds AI in fiscal 2025.
Which keeps more of its revenue as profit, McKesson or DataMeds AI?
McKesson had a net margin of 1.2% in fiscal 2026; DataMeds AI had -433.9% in fiscal 2025.
Which grew revenue faster, McKesson or DataMeds AI?
In their latest fiscal years revenue changed by +12.4% at McKesson and +28.7% at DataMeds AI.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.